Haloperidol for ICU Delirium Misses on Hard Endpoints

(MedPage Today) -- Intensive care unit (ICU) patients who received haloperidol (Haldol) for delirium fared no better on the AID-ICU trial's primary outcome at 3 months than those who received placebo.
At 90 days, the mean number of days alive...